Metabolism–epigenome crosstalk in physiology and diseases

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Human Genetics

• Publication date

  2013-05-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/jhg.2013.57PMID 23719186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetic Reprogramming in Cancer

  2013cited by this paper
• (R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible

  2013cited by this paper
• Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

  2012cited by this paper
• Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation.

  2012cited by this paper
• Sirtuins as regulators of metabolism and healthspan

  2012cited by this paper
• IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

  2012cited by this paper
• IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

  2012cited by this paper
• IDH mutations in acute myeloid leukemia.

  2012cited by this paper
• FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure

  2012cited by this paper
• Gatekeepers of chromatin: Small metabolites elicit big changes in gene expression.

  2012cited by this paper
• Molecular pathogenesis of IDH mutations in gliomas

  2012cited by this paper
• Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.

  2012cited by this paper
• Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.

  2012cited by this paper
• The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.

  2012cited by this paper
• The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation.

  2012cited by this paper
• The role of nutrition on epigenetic modifications and their implications on health.

  2012cited by this paper
• Role of DNA Methylation in the Regulation of Lipogenic Glycerol-3-Phosphate Acyltransferase 1 Gene Expression in the Mouse Neonatal Liver

  2012cited by this paper
• The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon.

  2011cited by this paper
• Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

  2011cited by this paper
• Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer

  2011cited by this paper
• The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases

  2011cited by this paper
• Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation.

  2011cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2010cited by this paper
• Epigenomic disruption: the effects of early developmental exposures.

  2010cited by this paper
• PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

  2010cited by this paper
• Oxygen in stem cell biology: a critical component of the stem cell niche.

  2010cited by this paper
• Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator–activated receptor γ coactivator 1α promoter

  2010cited by this paper
• Cellular bioenergetics as a target for obesity therapy

  2010cited by this paper
• Histone demethylases in development and disease.

  2010cited by this paper
• Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner.

  2010cited by this paper
• The epigenetic basis of the Warburg effect

  2010cited by this paper
• Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

  2010cited by this paper
• Increased Expression of DNA Methyltransferase 3a in Obese Adipose Tissue: Studies With Transgenic Mice

  2010cited by this paper
• ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation

  2009cited by this paper
• Epigenetic mechanisms that underpin metabolic and cardiovascular diseases

  2009cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2009cited by this paper
• Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

  2009cited by this paper
• A Novel Mammalian Flavin-dependent Histone Demethylase*

  2009cited by this paper
• Butyrate metabolism in human colon carcinoma cells: Implications concerning its growth‐inhibitory effect

  2009cited by this paper
• Role of Jhdm2a in regulating metabolic gene expression and obesity resistance

  2009cited by this paper
• Obesity and metabolic syndrome in histone demethylase JHDM2a‐deficient mice

  2009cited by this paper
• Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density.

  2009cited by this paper
• Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

  2008cited by this paper
• Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail

  2008cited by this paper
• Is mitochondrial dysfunction a cause of insulin resistance?

  2008cited by this paper
• Developmental origins of health and disease: new insights.

  2008cited by this paper
• Developmental origin of fat: tracking obesity to its source.

  2007cited by this paper
• Transcriptional regulation of metabolism.

  2006cited by this paper
• Histone demethylation by a family of JmjC domain-containing proteins

  2006cited by this paper
• Microbial degradation products influence colon cancer risk: the butyrate controversy.

  2004cited by this paper
• PGC-1α: Turbocharging mitochondria

  2004cited by this paper
• PGC-1alpha: turbocharging mitochondria.

  2004cited by this paper
• Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.

  2004cited by this paper
• Gene–Diet Interactions in Brain Aging and Neurodegenerative Disorders

  2003cited by this paper
• GeneDiet Interactions in Brain Aging and Neurodegenerative Disorders

  2003cited by this paper
• PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

  2003cited by this paper
• Inhibition of histone deacetylase activity by butyrate.

  2003cited by this paper
• Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

  2003cited by this paper
• Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice

  2002cited by this paper
• Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.

  2002cited by this paper
• Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

  2001cited by this paper
• The language of covalent histone modifications

  2000cited by this paper
• The riboflavin/FAD cycle in rat liver mitochondria.

  2000cited by this paper
• Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice

  1998cited by this paper
• Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis

  1992cited by this paper

• The AHCY–adenosine complex rewires mRNA methylation to enhance fatty acid biosynthesis and tumorigenesis

  2026cites this paper
• Assessing the effects of uracil-based pesticides on hepatic metabolic dysfunctions in low-cost three-dimensional multicellular spheroids.

  2025cites this paper
• Epigenome-metabolism nexus in the retina: implications for aging and disease.

  2024cites this paper
• T cell exhaustion in malignant gliomas.

  2023cites this paper
• Epigenetic dynamics during capacitation of naïve human pluripotent stem cells

  2023cites this paper
• Intermittent Fasting Sustainably Improves Glucose Tolerance in Normal Weight Male Mice Through Histone Hyperacetylation

  2023cites this paper
• Metabolome Shift in Both Metastatic Breast Cancer Cells and Astrocytes Which May Contribute to the Tumor Microenvironment

  2021cites this paper
• Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease

  2021cites this paper
• [Linkage of Drug Resistance and Metabolome Shift in Renal Cell Carcinoma Cells].

  2020cites this paper
• Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of Platelets

  2020cites this paper
• Peculiarities of Platelet Metabolism in Patients with Acute Coronary Syndrome with Anxiety–Depressive Disorders and Informativity of Enzymes in the Forecast of Development of Cardiovascular Complications

  2020cites this paper
• Cancer epigenetics in solid organ tumours: A primer for surgical oncologists.

  2019cites this paper
• Trichostatin A modulates cellular metabolism in renal cell carcinoma to enhance sunitinib sensitivity

  2019cites this paper
• Maternal nutrition, epigenetic programming and metabolic syndrome

  2019cites this paper
• The interaction between gut microbiome and nutrients on development of human disease through epigenetic mechanisms

  2019cites this paper
• Trained Innate Immunity and Its Implications for Mucosal Immunity and Inflammation.

  2019cites this paper
• Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction

  2018cites this paper
• LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation

  2018cites this paper
• Aging and nutrition induce tissue-specific changes on global DNA methylation status in rats.

  2018cites this paper
• Altered intracellular signaling by imatinib increases the anti‐cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells

  2017cites this paper
• Rate of entropy model for irreversible processes in living systems

  2017cites this paper
• The SETD8/PR-Set7 Methyltransferase Functions as a Barrier to Prevent Senescence-Associated Metabolic Remodeling.

  2017cites this paper
• Nutritional Epigenome and Metabolic Syndrome

  2017cites this paper
• Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells

  2016cites this paper
• Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells

  2016cites this paper
• Lysine-Specific Demethylase 2 Suppresses Lipid Influx and Metabolism in Hepatic Cells

  2015cites this paper
• Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene-induced senescent cells

  2015cites this paper
• Title : Lysine demethylase LSD 1 coordinates glycolytic and mitochondrial metabolism in hepatocellular carcinoma cells

  2015cites this paper
• Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD

  2015cites this paper
• DNA Methylation in Metabolic Diseases

  2015cites this paper
• Lysine Demethylase LSD1 Coordinates Glycolytic and Mitochondrial Metabolism in Hepatocellular Carcinoma Cells.

  2015cites this paper
• Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease.

  2015cites this paper
• Lysine Demethylase LSD 1 Coordinates Glycolytic and Mitochondrial Metabolism in Hepatocellular Carcinoma Cells

  2015cites this paper
• Sensing risk, fearing uncertainty: systems science approach to change

  2014cites this paper
• The impact of DNA methylation technologies on drug toxicology

  2014cites this paper
• High-throughput sperm differential proteomics suggests that epigenetic alterations contribute to failed assisted reproduction.

  2014cites this paper
• Epigenetically active drugs target metabolic gene-regulation in leukemic cells

  2013cites this paper